Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00947453Phase 2Completed
Phase 2, randomised, double-blind trial in asthma comparing Montelukast Group with Placebo Group (2 arms). Primary endpoint: MMP and TIMP mRNA profile relative to a housekeeping gene at 8 weeks. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00947453.